• Home
  • >
  • Ind Swift Laboratories Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/BlinkxSearch/initials/i.svg Logo

Ind Swift Laboratories Ltd Financial Statement

Ind Swift Laboratories Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Mar 2024Dec 2023Sep 2023
Revenue793.57283.4277.7
Operating Expense309.22222.04206.9
Net Profit349.5921.6530.1
Net Profit Margin44.057.6410.84
Earning Per Share59.173.665.09
EBIDTA495.1961.3570.81
Effective Tax Rate29.828.39.01

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Ind Swift Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual1,207.311,038.73891.34
Operating Expenses Annual978.11843.11708.52
Operating Profit Annual236.05239.12205.52
Interest Annual92.1795.55100.22
Depreciation57.36131.0487.29
Net Profit Annual47.6-2.15-3.15
Tax Annual38.6914.6821.16

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Ind Swift Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning21.4811.610.58
Cash Flow from Operations194.62150.27134.95
Cash Flow from Investing-13.374.77-10.17
Cash Flow from Financing-185.66-140.88-123.75
Cash Flow at the End17.0725.7711.61

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Ind Swift Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)21.7623.6523.06
PBIT Margin (%)17.0111.0413.26
PBT Margin (%)16.8210.9213.12
Net PROFIT Margin (%)3.69-0.58-0.51
Return On Networth / Equity (%)13.24TBATBA
Return On Networth /Employed(%)14.76TBATBA
Return On Assets (%)2.84-0.38-0.28
Total Debt / Equity(X)1.942.252.39
Asset Turnover Ratio (%)0.770.650.54

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Ind Swift Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual585.04628.53746.8
Total Current Assets Annual1,164.521,075.33944.18
Non Current Assets Annual659.55725.46874.27
Total Shareholders Funds Annual681.93600.97603.51
Total Assets Annual1,824.061,800.791,818.45

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Ind Swift Laboratories Ltd Earning Calls
Mar 2024
EPS beaten by 0.00 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Ind Swift Laboratories Ltd has a market capitalization of 580.82 Cr. Value Research classifies it as a Small-Cap company.

Yes, Ind Swift Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.02.

In FY 2023, Ind Swift Laboratories Ltd recorded a total revenue of approximately 1,280.9 Cr marking a significant milestone in the company's financial performance.

Ind Swift Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.2% and 0.1% annually, respectively..

Ind Swift Laboratories Ltd's current PE ratio is 1.38.

Ind Swift Laboratories Ltd's ROCE averaged 15.4% from the FY ending March 2022 to 2024, with a median of 13.3%. It peaked at 26.0% in March 2024, reflecting strong capital efficiency over the period..

Ind Swift Laboratories Ltd's latest EBIT is Rs. 632.86 Cr, surpassing the average EBIT of Rs. 306.54 Cr over the 5 years..